ABSTRACT Background: Despite the high content of palmitic acid, palm olein has been shown to have a neutral effect on plasma cholesterol concentrations when compared with olive oil, which is suggested to be attributable to palmitic acid in the sn-1 and sn-3 position. In contrast, palmitic acid is in the sn-2 position in lard. Objective: The objective was to investigate the effects of a diet rich in palm olein, fractionated palm oil, olive oil, and lard on plasma blood lipids, inflammatory markers, glucose, and insulin. Design: A controlled double-blinded, randomized 3 · 3 wk crossover dietary intervention study included 32 healthy men who daily replaced part of their habitual dietary fat intake with ;17% of energy from palm olein, olive oil, or lard, respectively. Results: Compared with intake of olive oil, palm olein and lard increased total cholesterol and LDL cholesterol (P , 0.0001). Palm olein resulted in a lower plasma triacylglycerol concentration than did olive oil (P , 0.01). No difference in effects was observed in plasma HDL-cholesterol, high-sensitivity C-reactive protein, plasminogen activator-1, insulin, and glucose concentrations. Conclusions: The current study did not support the previous finding that the effect of palm olein on total plasma cholesterol and LDL cholesterol in healthy individuals with normal plasma cholesterol concentrations is neutral compared with that of olive oil. Thus, snpositioning was not confirmed to be important with regard to the effect on plasma cholesterol. The relatively lower plasma triacylglycerol concentration after the palm olein diet than after the olive oil diet was unexpected. This trial is registered at clinicaltrials.gov as NCT00743301.
INTRODUCTION
It is well established that dietary fats high in long-chain SFA, lauric (12:0), myristic (14:0), and palmitic acid (16:0) increase plasma total cholesterol and LDL cholesterol concentration, whereas stearic acid (18:0) does not increase total plasma and LDL cholesterol (1) (2) (3) . Palm oil has a high content of the SFA palmitic acid and a low content of unsaturated fatty acid. Studies from the 1960s suggested that palmitic acid is the primary contributor to increased serum cholesterol concentrations in humans (4) , which is in agreement with a more recent metaanalysis (5) that included selected intervention studies on palmitic acid, primarily from palm oil. However, despite its high content of palmitic acid, palm olein (a fraction of palm oil with a relatively high content of oleic acid) was demonstrated to have a neutral effect on plasma cholesterol concentration when compared with olive oil (6) , confirmed later in an Australian study (7) . Thus, it was of interest to reproduce the earlier findings that palm olein did not raise plasma cholesterol compared with olive oil. A Chinese study from the 1990s reported that palm oil lowered plasma cholesterol compared with lard (8) . As both palm olein and lard contain a high and rather equal amount of SFA, it has been hypothesized that the lesser cholesterol-raising effect of palm oil was due to a different positioning of palmitic acid in the 2 fats. Thus, in palm olein, palmitic acid is placed in the sn-1 and sn-3 positions of the glycerol backbone, whereas it is positioned in the sn-2 position in lard (9) . Fatty acids in the sn-2 position are mainly absorbed through the intestinal wall, whereas fatty acids in the sn-1 and sn-3 positions are released in the intestinal tract (by lipase) and partly excreted in the feces through formation of calcium soaps (8) . Fatty acids in the sn-2 position are preferentially transported to the liver instead of the extrahepatic tissues (10) and thereby affect LDL metabolism (11) . Animal studies have shown an effect of the sn-positioning (9, 12) , which was also the case in infants (13) ; however, this effect has not yet been confirmed in human studies (14) . We performed a controlled dietary intervention study in men in which we compared the effects of diets high in palm olein, olive oil, or lard. The aim was to compare the effects of a diet rich in palm olein to a diet rich in olive oil and a diet rich in lard on serum total, LDL, and HDL cholesterol, as well as triacylglycerol in healthy men; secondarily, the aim was to compare these dietary fats on supplemental risk markers of CVD 4 : fasting insulin, glucose, PAI-1, and hsCRP.
SUBJECTS AND METHODS

Subjects
Apparently healthy men who ranged in age from 19 to 64 y were recruited for the study through announcements in local newspapers. Approximately 374 men were invited to information meetings; 78 were selected for screening, and 45 were enrolled as study participants. Eleven participants with a baseline total cholesterol concentration .5.2 mmol/L were excluded from the statistical analysis, which was performed on the remaining 32 participants. All subjects were apparently healthy as indicated by a medical and lifestyle questionnaire. Exclusion criteria were as follows: BMI (in kg/m 2 ) .30, hypertension, chronic disease, or regular use of medication. We instructed all participants to maintain the same level of physical activity throughout the study. All subjects agreed to refrain from donating blood for 2 mo before and during the study and to refrain from taking dietary supplements that might interfere with study measurements. To estimate the participants' energy levels before the intervention started, we obtained information at the screening interview about their PAL at work and in their spare time. The energy estimation is based on the Commission of the European Communities and WHO/FAO/UNO prediction equations for basal energy expenditure multiplied by PAL. PAL is expressed as multiples of basal energy expenditure according to different concentrations of occupational and leisure activity (15) .
Study design and diet
The study was a double-blinded, randomized, 3 · 3 wk crossover intervention study without washout periods. The experimental test fats were palm olein, olive oil, and lard, which were incorporated into buns and cakes, both common food items in the Danish diet. The participants were provided with the test food that partially substituted their daily diet and replaced ;17% of energy from the daily fat intake. Each participant was allocated to a diet with low (12 MJ), medium (13-14 MJ), or high (15 MJ) energy level according to their estimated daily energy expenditure. Each energy level matched the low-, medium-, or high-fat content in the test diet, which was to substitute 17% of energy. The macronutrient compositions of the test diets were identical (eg, % of energy as carbohydrates, protein, and fat), whereas the fatty acid compositions differed ( Table 1) . The diets were given to the participants in random order. The palm oil was provided by MPOB, the olive oil by Karlshamns BV, and the lard by Dragsbaek. All fats were refined, which diminished the smell and taste less and minimized the content of nonglyceride components.
The participants completed a 3-d weighed food record 1 or 2 wk before the intervention and in the middle of each diet period to ensure stable weight and to obtain information about additional fat intake. One weekend day was to be included in the dietary survey period to account for any weekend effect on nutrient intake. All participants were given written and oral information about the 3-d food records. The participants were given feedback and advice, after delivering the first food record, on how they could decrease their fat intake during the intervention period. The reported intake of fatty acids during the intervention study mirrored the content of fatty acids in the test diet (ie, a higher intake of SFAs during the palm olein and lard diets than during the olive oil diet; P , 0.0001 for both). The reported intake of dietary MUFAs reflected the content in the test fats, because the intake was higher during the olive oil diet than during the 2 other diets (P , 0.0001 for both), whereas no difference between intakes during the palm olein and lard diets was found. In addition, intake of PUFA was reported to be higher during the palm olein diet than during the lard diet (P , 0.001) and olive oil diet (P , 0.01), which agrees with the slightly higher content of PUFAs in the palm olein diet. The study was carried out in accordance with the Helsinki Declaration and was approved by the Danish National Committee on Biomedical Research Ethics (report no. H-B-2008-056).
Blood analysis
Blood samples were collected, after the subjects had fasted for 12 h, on consecutive days at baseline and at the end of each diet period after 10 min of supine rest. The subjects were asked to refrain from alcohol intake for 24 h before and heavy physical activity for 36 h before the blood samples were collected.
Blood lipids
Blood samples were collected for the measurement of serum blood lipids (triacylglycerol, total cholesterol, and LDL and HDL cholesterol). The blood samples were collected into dry tubes (1 · 10 mL) and were centrifuged at 2200 · g for 20 min at 22°C. The serum for blood lipids was stored at 280°C until the samples were analyzed. LDL and HDL cholesterol were assessed by using an enzymatic colorimetric procedure (ABX Pentra LDL Direct CP and ABX Pentra HDL direct CP; Horiba ABX). Cholesterol and triacylglycerol concentrations were assessed in serum by using enzymatic procedures (CHOD-PAP and GPO-PAP, respectively). CHOD-PAP is an enzymatic photometric test, whereas GPO-PAP is an enzymatic colorimetric test. The kits were from ABX Pentra Cholesterol CP and ABX Pentra Triglycerides CP. The analysis was carried out with an ABX Pentra 400 Chemistry Analyzer. The interassay CVs for total, LDL, and HDL cholesterol and triacylglycerol were 0.68%, 3.22%, 1.28%, and 3.57%, respectively. The intraassay CVs for total, LDL, and HDL cholesterol and triacylglycerol were 0.9%, 2.55%, 1.26%, and 1.49%, respectively.
Inflammatory markers
The blood samples for hsCRP were collected into dry tubes. After coagulation, the samples were centrifuged at 2200 · g for 20 min at 22°C and stored at 280°C until analyzed. Serum CRP concentrations were measured by using a high-sensitive 
Plasma glucose and serum insulin
The blood samples for glucose and insulin measurements were collected into tubes containing a 1 · 3 mL fluoride-citrate mixture, which stabilizes the glucose content. Each tube was slowly twisted 10 times. The samples were centrifuged at 2200 · g for 20 min at 22°C. Plasma glucose and serum insulin were stored at 280°C until analyzed. Glucose was analyzed with an ABX Pentra 400 Chemistry Analyzer, whereas insulin was analyzed with a DPC Immulite 1000 (Siemens Medical Solution Diagnostics. The inter-and intraassay CVs for plasma glucose were 2.01% and 2.15%, respectively, and for serum insulin were 2.72% and 2.94%, respectively.
Statistics
The outcome variables were analyzed by using a linear mixed model incorporating systematic effects of period and treatment and their interaction, a carryover effect, and explanatory variables (age, baseline measurements, energy intake, familial CVD, fat intake, period, and smoking), which were included to adjust for possible differences between subjects.
Subject-specific random effects were included to account for intersubject variability and to adjust for any nonspecific differences that could not be explained by the explanatory variables included. Model checking was based on graphic assessment by using normal probability plots and residual plots. If deviations from the model assumptions were detected, outcome variables were transformed by using appropriate transformations.
Approximate F tests were used to assess the effect of period and treatment and the effect of 2 explanatory variables (fat intake and smoking). Model-based least-squares means were used to quantify the treatment effects and test for differences between treatments by using post hoc t tests. PROC MIXED in Statistical Analysis System (version 9.1; SAS Institute) was used for the analyses.
RESULTS
Subject characteristics
Of the 45 participants who started the study, 43 completed the study. An additional 11 participants were excluded from the statistical analysis because of a baseline cholesterol concentration .5.2 mmol/L. Baseline characteristics of the remaining 32 participants are listed in Table 2 .
Dietary intake
The calculated nutrient composition of the 3 treatment diets is shown in Table 3 . The changes in fatty acid composition of the participants' diets during the 3 intervention periods reflected the fatty acid composition in the test fats very well. No differences in the reported intakes of energy, alcohol, dietary fiber, or macronutrient composition (ie, percentage of energy from protein, fat, and carbohydrates) were observed during the periods with different test diets.
Body weight
On average, all participants gained 0.8 kg, which was within our limit of 61 kg that reflects day-to-day variation and is an acceptable weight change. However, we found a tendency for the participants to gain slightly more weight (0.3 kg) during the olive oil diet than during the palm olein diet (P , 0.001). Thus, body weights were 76.2 6 8.6 kg after the palm olein diet, 76.1 6 8.7 kg after the lard diet, and 76.5 6 8.8 kg after the olive oil diet.
Plasma and serum variables
We found a significantly lower triacylglycerol concentration after the palm olein-rich diet than after the olive oil-rich diet (P , 0.01). Furthermore, total cholesterol and LDL cholesterol were significantly lower after the olive oil-rich diet than after the diets rich in palm olein or lard (P , 0.0001). Mean values for plasma lipids are shown in Figure 1 . No differences were found between the effect of palm olein and lard on total cholesterol, LDL-cholesterol, and triacylglycerol concentrations. No statistically significant differences were found between the effects of the 3 test diets on HDL cholesterol, total:HDL cholesterol ratio, hsCRP, insulin, glucose, or PAI-1; however, the difference between total:HDL cholesterol tended to be lower after the olive oil-rich diet than after the 2 other diets (P = 0.07 against lard and P = 0.17 against palm olein). PAI-1, hsCRP, insulin, and glucose concentrations at baseline and at the end of each dietary treatment are shown in Table 4 .
DISCUSSION
The most important result from the study was that palm olein increased total and plasma LDL cholesterol compared with olive oil, whereas palm olein and lard did not affect total and LDL cholesterol differently. The moderate increase in plasma cholesterol with palm olein compared with olive oil agreed with the findings by others (2) and with expected values obtained with Key's predictive formula for changes in plasma cholesterol (4). Thus, the predicted change in total plasma cholesterol was ;4% with Key's equation, which agrees well with the observed value of 4.5%. The predicted value obtained with use of the formula of Mensink and Katan (1) was slightly lower (3%) but still agreed well with our findings. Thus, previous findings with a similar effect of palm olein and olive oil on total cholesterol concentrations (7) could not be confirmed when the predictive formula was used for changes in cholesterol or by our findings. We observed no difference in LDL cholesterol concentrations between the palm olein and lard diet periods. This finding disagrees with the results from a Chinese study (8) , in which a total fat intake of 30% of energy from palm oil resulted in lower total and LDL-cholesterol concentrations. In contrast, the results from a recent study with the aim of comparing the cholesterolemic influence of palmitic acid in the sn-1 and sn-2 positions reported slightly higher plasma cholesterol after palm oil than after lard (16) . However, overall, our results agree with the predicted values obtained with the formula of Keys et al (4) and of Mensink et al (5), which showed changes of 1.4% and 0.7%, respectively, after palm olein compared with those after lard. We were unable to explain the discrepancy between our findings and those of the Chinese study, which observed lower plasma cholesterol after palm oil than after lard. Our participants had a higher total fat intake (35% of energy) than did the participants of the Chinese study (30% of energy), which should not have affected the results. Also, our participants were Danes, who were used to different dietary patterns than the Chinese. In addition, a genetic difference might have played a role; however, this finding disagreed with that of others (8) . Although our study was not designed to compare the effects of palmitic acid in sn positions, our results do not support the hypothesis that palmitic acid in the sn-1 and sn-3 positions is less cholesterolemic than palmitic acid in the sn-2 position and neither do the results of the British study that investigated the cholesterol fractional synthesis rate by 2 H incorporation (16) . Although animal studies (17, 18) and studies in newborns (13) have shown effects of the sn-configuration of fatty acids, this effect could not be confirmed in human studies (14) . Zock et al (10) concluded that a large difference in fatty acid configurations (eg, sn position) had little effect on blood lipid and lipoprotein concentrations, which is supported by others (19, 20) . No significant differences in the total:HDL cholesterol ratio, which is suggested to be a predictor of CVD development rather than LDL per se (21), were found after intake of the different test 2 All values are means 6 SDs.
3 All values are least-squares means 6 SDs. 4 Excluding test fats. 5 Including test fats.
diets; however, slight tendencies to a lower ratio were found after the olive oil diet than after the palm olein and lard diets (with lard resulting in the less beneficial ratio). This may be a consequence of the slightly lower LDL-cholesterol concentration after intake of olive oil. Palm olein resulted in a lower plasma triacylglycerol concentration than did olive oil. It is well established that dietary fats high in SFAs result in higher HDL-cholesterol concentrations than do unsaturated fats (22) and that an inverse relation between plasma triacylglycerol and HDL cholesterol exists because of increased cholesteryl ester transfer protein activity (23) . Thus, we speculate that a lower cholesteryl ester transfer protein activity may be at least a part of the explanation. The reported intake of fatty acids during the intervention study mirrored the content of fatty acids in the test diet and indicated a good compliance among the participants. FIGURE 1. Least-squares mean (6SE) plasma concentrations of total, LDL, and HDL cholesterol and TAG in 32 young men after a 3-wk intervention consisting of diets rich in palm olein (black shading), olive oil (white shading), or lard (gray shading). Model-based least-squares means were used to quantify the treatment effects and test for differences between treatments by using post hoc t tests. 
Study limitations
The overall weight gain in this study was so small that it likely had no clinical relevance. Furthermore, the higher weight gain during the olive oil diet contrasted with the reported lower total and LDL-cholesterol values. Another concern was that the higher intake of energy, especially from fat, during the intervention potentially might have masked any effects of the test diets. However, if the amount of fat in the diets blurred the results by increasing the total and LDL-cholesterol concentrations, we would have expected it to do so evenly because of the crossover design during all 3 test diet periods. In addition, the participants reported a higher intake of cholesterol (;50 mg/d) from nontest foods (ie, the background diet) during the palm olein and lard diets than during the olive oil diet (P , 0.0001 and 0.001, respectively). We cannot explain this finding, which may be an artifact. It is possible that the participants registered their diet on 3 d, 4 times during the study. It is possible that the participants ate fewer cholesterol-containing foods on those 3 d on the olive oil-rich diet than on the others days. However, this may not have affected the results because the dietary intake of cholesterol in healthy people only negligibly influences the serum cholesterol concentrations (24) observed in many studies (25) . Thus, an estimate of how an increased intake of cholesterol affects serum cholesterol concentrations was made by Weggemans et al (24) in a meta-analysis. They estimated that an increase of 100 mg cholesterol/d would lead to an increase in serum total cholesterol of 0.056 mmol/L, which means that the difference in intake of 50 mg/d in our study may have affected plasma cholesterol concentrations only marginally.
Overall, the differences in the effect on total cholesterol of palm olein between olive oil and lard were small (4.5%) and may not be of any clinical significance. In addition, evidence that SFAs increase the risk of CVD is questionable (26) . A recent metaanalysis in ;248,000 persons concluded that there is no significant evidence that dietary SFA intake is associated with an increased risk of CHD (27) . Thus, although LDL cholesterol is an established risk factor for CVD, some properties associated with SFAs may counteract the harmful LDL cholesterol-raising effect. We speculated that larger, and thereby more beneficial, LDL particles formed after intake of SFA may penetrate arteries to a lesser extent, as suggested previously (28) . The HDL-raising effect of SFAs may be even more protective than suggested. Finally, SFA intake results in a lower oxidative stress than does intake of unsaturated fatty acids. More research is needed to elucidate this paradox.
Conclusion
The current study did not support the previous finding that the effect of palm olein on total plasma cholesterol and LDL cholesterol in healthy individuals with normal plasma cholesterol concentrations is neutral compared with that of olive oil. Thus, a diet rich in olive oil resulted in a slightly lower, however consistent and thereby more favorable, plasma LDL-cholesterol concentration than did a diet rich in palm olein and lard. Also, the total:HDL cholesterol ratio was slightly, but not significantly, lower after the olive oil diet than after the other diets. The relatively lower, and thereby more beneficial, plasma triacylglycerol concentration after the palm olein diet than after the olive oil diet was unexpected and may have been a beneficial effect of palm olein per se.
